Lista de obras -

A standardised method for interpreting the association between mutations and phenotypic drug resistance in Mycobacterium tuberculosis

artículo científico publicado en 2017

Cigarette-Smoking Intensity and Interferon-Gamma Release Assay Conversion among Persons Who Inject Drugs: A Cohort Study

artículo científico publicado en 2012

Correlating Minimum Inhibitory Concentrations of ofloxacin and moxifloxacin with gyrA mutations using the genotype MTBDRsl assay

artículo científico publicado en 2014

Correlating rrs and eis promoter mutations in clinical isolates of Mycobacterium tuberculosis with phenotypic susceptibility levels to the second-line injectables

artículo científico publicado en 2015

Corrigendum to "Correlating rrs and eis promoter mutations in clinical isolates of Mycobacterium tuberculosis with phenotypic susceptibility levels to the second-line injectables" [Int. J. Mycobacteriol. 5(1) 2016 1-6].

artículo científico publicado en 2016

Cost analysis of rapid diagnostics for drug-resistant tuberculosis.

artículo científico publicado en 2018

Defining multidrug-resistant tuberculosis: correlating GenoType MTBDRplus assay results with minimum inhibitory concentrations

artículo científico publicado en 2015

Detection of Low-Level Mixed-Population Drug Resistance in Mycobacterium tuberculosis Using High Fidelity Amplicon Sequencing

artículo científico publicado en 2015

Evaluation of genetic mutations associated with Mycobacterium tuberculosis resistance to amikacin, kanamycin and capreomycin: a systematic review

artículo científico publicado en 2012

Evaluation of pyrosequencing for detecting extensively drug-resistant Mycobacterium tuberculosis among clinical isolates from four high-burden countries

artículo científico publicado en 2014

Evaluation of the microscopic observation drug susceptibility assay for the detection of first- and second-line drug susceptibility for Mycobacterium tuberculosis.

artículo científico publicado en 2017

Factors associated with genotype clustering of Mycobacterium tuberculosis isolates in an ethnically diverse region of southern California, United States

artículo científico publicado en 2012

Frequency and geographic distribution of gyrA and gyrB mutations associated with fluoroquinolone resistance in clinical Mycobacterium tuberculosis isolates: a systematic review

artículo científico publicado en 2015

Genetic mutations associated with isoniazid resistance in Mycobacterium tuberculosis: a systematic review

artículo científico publicado en 2015

HIV infection risk among injection drug users in a methadone maintenance treatment program, Taipei, Taiwan 2007-2010.

artículo científico publicado en 2012

Healthcare barriers of refugees post-resettlement

artículo científico publicado en 2009

Host Biomarkers for Distinguishing Bacterial from Non-Bacterial Causes of Acute Febrile Illness: A Comprehensive Review

artículo científico publicado en 2016

Impact of fluoroquinolone use on mortality among a cohort of suspected drug-resistant tuberculosis patients.

artículo científico publicado en 2017

Increased Tuberculosis Patient Mortality Associated with Mycobacterium tuberculosis Mutations Conferring Resistance to Second-Line Antituberculous Drugs.

artículo científico publicado en 2017

Latent tuberculosis among persons at risk for infection with HIV, Tijuana, Mexico

artículo científico publicado en 2010

MTBDRplus and MTBDRsl Assays: Absence of Wild-Type Probe Hybridization and Implications for Detection of Drug-Resistant Tuberculosis.

artículo científico publicado en 2016

Next-generation sequencing-based user-friendly platforms for drug-resistant tuberculosis diagnosis: A promise for the near future

artículo científico publicado en 2016

Novel katG mutations causing isoniazid resistance in clinical M. tuberculosis isolates.

artículo científico publicado en 2015

Pandemic (H1N1) 2009 Surveillance in Marginalized Populations, Tijuana, Mexico

artículo científico publicado en 2010

Performance Comparison of Three Rapid Tests for the Diagnosis of Drug-Resistant Tuberculosis

artículo científico publicado en 2015

Performance of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis and rifampin resistance in a low-incidence, high-resource setting

artículo científico publicado en 2017

Predicting extensively drug-resistant Mycobacterium tuberculosis phenotypes with genetic mutations

artículo científico publicado en 2014

Prevalence and treatment of latent tuberculosis infection among newly arrived refugees in San Diego County, January 2010-October 2012.

artículo científico publicado en 2014

Pyrosequencing for rapid detection of extensively drug-resistant Mycobacterium tuberculosis in clinical isolates and clinical specimens

artículo científico publicado en 2013

Quantitative measurement of antibiotic resistance in Mycobacterium tuberculosis reveals genetic determinants of resistance and susceptibility in a target gene approach

artículo científico publicado en 2024

Rapid Drug Susceptibility Testing of Drug-Resistant Mycobacterium tuberculosis Isolates Directly from Clinical Samples by Use of Amplicon Sequencing: a Proof-of-Concept Study

artículo científico publicado en 2016

Requiring smartphone ownership for mHealth interventions: who could be left out?

scientific article published on 20 January 2020

Rifabutin and rifampin resistance levels and associated rpoB mutations in clinical isolates of Mycobacterium tuberculosis complex

artículo científico publicado en 2016

Shedding light on the performance of a pyrosequencing assay for drug-resistant tuberculosis diagnosis.

artículo científico publicado en 2016

Surveillance or support: The experience of direct observation during tuberculosis treatment.

artículo científico publicado en 2016

Target Product Profile for a Diagnostic Assay to Differentiate between Bacterial and Non-Bacterial Infections and Reduce Antimicrobial Overuse in Resource-Limited Settings: An Expert Consensus

artículo científico publicado en 2016

The Global Consortium for Drug-resistant Tuberculosis Diagnostics (GCDD): design of a multi-site, head-to-head study of three rapid tests to detect extensively drug-resistant tuberculosis

artículo científico publicado en 2014

Tracing the origins of Mycobacterium bovis tuberculosis in humans in the USA to cattle in Mexico using spoligotyping

artículo científico publicado en 2010

Trends in mortality of tuberculosis patients in the United States: the long-term perspective

artículo científico publicado en 2011

Tuberculosis and illicit drug use: review and update

artículo científico publicado en 2009

Tuberculosis from Mycobacterium bovis in binational communities, United States

artículo científico publicado en 2008

Tuberculosis testing among populations with high HIV risk in Tijuana, Baja California, Mexico

artículo científico publicado en 2012

Under- and over-nutrition among refugees in San Diego County, California

artículo científico publicado en 2011

Updating the WHO target product profile for next-generation Mycobacterium tuberculosis drug susceptibility testing at peripheral centres ⬇️

artículo científico publicado en 2023

Whole-genome and targeted sequencing of drug-resistant Mycobacterium tuberculosis on the iSeq100 and MiSeq: A performance, ease-of-use, and cost evaluation

artículo científico publicado en 2019

Wild African elephants (Loxodonta africana) discriminate between familiar and unfamiliar conspecific seismic alarm calls

artículo científico publicado en 2007

Lista de obras de

A standardised method for interpreting the association between mutations and phenotypic drug resistance in Mycobacterium tuberculosis

Cigarette-Smoking Intensity and Interferon-Gamma Release Assay Conversion among Persons Who Inject Drugs: A Cohort Study

Correlating Minimum Inhibitory Concentrations of ofloxacin and moxifloxacin with gyrA mutations using the genotype MTBDRsl assay

Correlating rrs and eis promoter mutations in clinical isolates of Mycobacterium tuberculosis with phenotypic susceptibility levels to the second-line injectables

Corrigendum to "Correlating rrs and eis promoter mutations in clinical isolates of Mycobacterium tuberculosis with phenotypic susceptibility levels to the second-line injectables" [Int. J. Mycobacteriol. 5(1) 2016 1-6].

Cost analysis of rapid diagnostics for drug-resistant tuberculosis.

Defining multidrug-resistant tuberculosis: correlating GenoType MTBDRplus assay results with minimum inhibitory concentrations

Detection of Low-Level Mixed-Population Drug Resistance in Mycobacterium tuberculosis Using High Fidelity Amplicon Sequencing

Evaluation of genetic mutations associated with Mycobacterium tuberculosis resistance to amikacin, kanamycin and capreomycin: a systematic review

Evaluation of pyrosequencing for detecting extensively drug-resistant Mycobacterium tuberculosis among clinical isolates from four high-burden countries

Evaluation of the microscopic observation drug susceptibility assay for the detection of first- and second-line drug susceptibility for Mycobacterium tuberculosis.

Factors associated with genotype clustering of Mycobacterium tuberculosis isolates in an ethnically diverse region of southern California, United States

Frequency and geographic distribution of gyrA and gyrB mutations associated with fluoroquinolone resistance in clinical Mycobacterium tuberculosis isolates: a systematic review

Genetic mutations associated with isoniazid resistance in Mycobacterium tuberculosis: a systematic review

HIV infection risk among injection drug users in a methadone maintenance treatment program, Taipei, Taiwan 2007-2010.

Healthcare barriers of refugees post-resettlement

Host Biomarkers for Distinguishing Bacterial from Non-Bacterial Causes of Acute Febrile Illness: A Comprehensive Review

Impact of fluoroquinolone use on mortality among a cohort of suspected drug-resistant tuberculosis patients.

Increased Tuberculosis Patient Mortality Associated with Mycobacterium tuberculosis Mutations Conferring Resistance to Second-Line Antituberculous Drugs.

Latent tuberculosis among persons at risk for infection with HIV, Tijuana, Mexico

MTBDRplus and MTBDRsl Assays: Absence of Wild-Type Probe Hybridization and Implications for Detection of Drug-Resistant Tuberculosis.

Next-generation sequencing-based user-friendly platforms for drug-resistant tuberculosis diagnosis: A promise for the near future

Novel katG mutations causing isoniazid resistance in clinical M. tuberculosis isolates.

Pandemic (H1N1) 2009 Surveillance in Marginalized Populations, Tijuana, Mexico

Performance Comparison of Three Rapid Tests for the Diagnosis of Drug-Resistant Tuberculosis

Performance of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis and rifampin resistance in a low-incidence, high-resource setting

Predicting extensively drug-resistant Mycobacterium tuberculosis phenotypes with genetic mutations

Prevalence and treatment of latent tuberculosis infection among newly arrived refugees in San Diego County, January 2010-October 2012.

Pyrosequencing for rapid detection of extensively drug-resistant Mycobacterium tuberculosis in clinical isolates and clinical specimens

Quantitative measurement of antibiotic resistance in Mycobacterium tuberculosis reveals genetic determinants of resistance and susceptibility in a target gene approach

Rapid Drug Susceptibility Testing of Drug-Resistant Mycobacterium tuberculosis Isolates Directly from Clinical Samples by Use of Amplicon Sequencing: a Proof-of-Concept Study

Requiring smartphone ownership for mHealth interventions: who could be left out?

Rifabutin and rifampin resistance levels and associated rpoB mutations in clinical isolates of Mycobacterium tuberculosis complex

Shedding light on the performance of a pyrosequencing assay for drug-resistant tuberculosis diagnosis.

Surveillance or support: The experience of direct observation during tuberculosis treatment.

Target Product Profile for a Diagnostic Assay to Differentiate between Bacterial and Non-Bacterial Infections and Reduce Antimicrobial Overuse in Resource-Limited Settings: An Expert Consensus

The Global Consortium for Drug-resistant Tuberculosis Diagnostics (GCDD): design of a multi-site, head-to-head study of three rapid tests to detect extensively drug-resistant tuberculosis

Tracing the origins of Mycobacterium bovis tuberculosis in humans in the USA to cattle in Mexico using spoligotyping

Trends in mortality of tuberculosis patients in the United States: the long-term perspective

Tuberculosis and illicit drug use: review and update

Tuberculosis from Mycobacterium bovis in binational communities, United States

Tuberculosis testing among populations with high HIV risk in Tijuana, Baja California, Mexico

Under- and over-nutrition among refugees in San Diego County, California

Updating the WHO target product profile for next-generation Mycobacterium tuberculosis drug susceptibility testing at peripheral centres ⬇️

Whole-genome and targeted sequencing of drug-resistant Mycobacterium tuberculosis on the iSeq100 and MiSeq: A performance, ease-of-use, and cost evaluation

Wild African elephants (Loxodonta africana) discriminate between familiar and unfamiliar conspecific seismic alarm calls